Umbilical Cord Blood Use For Admission Blood Tests of Very Low Birth Weight Preterm Neonates: A Multi-center Randomized Clinical Trial
NCT ID: NCT02103296
Last Updated: 2021-08-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2014-02-28
2021-07-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Autologous Umbilical Cord Blood Transfusion for Preterm Neonates
NCT01121328
Delayed Clamping and Milking the Umbilical Cord in Preterm Infants
NCT02092103
Combining Restrictive Guidelines and a NIRS SCORE to Decrease RBC Transfusions
NCT02535208
Utility of Placental/Umbilical Cord Blood in Early Onset Neonatal Sepsis in Very Low Birth Weight Infants
NCT03694613
Effect of Timing of Umbilical Cord Clamping on Anaemia at 8 and 12 Months and Later Neurodevelopment
NCT02222805
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Infant Blood
Control group. Admission labs to be drawn directly from the infant.
Drawing admission labs from infant blood
Cord Blood
Admission labs to be drawn from the infant's cord blood
Drawing admission labs from cord blood
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Drawing admission labs from cord blood
Drawing admission labs from infant blood
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1 Day
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
C.R.Darnall Army Medical Center
FED
Walter Reed National Military Medical Center
FED
United States Naval Medical Center, Portsmouth
FED
Madigan Army Medical Center
FED
Tripler Army Medical Center
FED
Capt Alicia Prescott
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Capt Alicia Prescott
Associate Investogator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thornton S Mu, MD
Role: PRINCIPAL_INVESTIGATOR
San Antonio Military Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tripler Army Medical Center
Honolulu, Hawaii, United States
Walter Reed National Military Medical Center
Bethesda, Maryland, United States
Carl R. Darnall Army medical Center
Fort Hood, Texas, United States
San Antonio Military Medical Center
Fort Sam Houston, Texas, United States
Portsmouth Naval Medical Center
Portsmouth, Virginia, United States
Madigan Army Medical Center
Tacoma, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mu TS, Prescott AC, Haischer-Rollo GD, Aden JK, Shapiro JB. Umbilical Cord Blood Use for Admission Blood Tests of VLBW Preterm Neonates: A Randomized Control Trial. Am J Perinatol. 2023 Jul;40(10):1119-1125. doi: 10.1055/s-0041-1733781. Epub 2021 Aug 18.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
393720-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.